Rtor.org - Real-Time Oncology Review | FDA

Provided by Alexa ranking, rtor.org has ranked N/A in N/A and 499,703 on the world. rtor.org reaches roughly 6,303 users per day and delivers about 189,083 users each month. The domain rtor.org uses a Commercial suffix and it's server(s) are located in N/A with the IP number 162.252.214.163 and it is a .org domain.

WEBJun 30, 2022 · The Oncology Center of Excellence Real-Time Oncology Review (RTOR) aims to provide a more efficient review process to ensure that safe and effective treatments are available to patients as...

List of domain same IP 162.252.214.163

Search Results related to rtor.org on Search Engine

Real-Time Oncology Review | FDA
fda.gov

https://www.fda.gov/about-fda/oncology-center-excellence/real-time-oncology-review

WEBJun 30, 2022 · The Oncology Center of Excellence Real-Time Oncology Review (RTOR) aims to provide a more efficient review process to ensure that safe and effective treatments are available to patients as...

DA: 100 PA: 7 MOZ Rank: 72

Real-Time Oncology Review (RTOR) | FDA
fda.gov

https://www.fda.gov/regulatory-information/search-fda-guidance-documents/real-time-oncology-review-rtor

WEBJul 22, 2022 · The purpose of this guidance is to provide recommendations to applicants on the process for submission of selected New Drug Applications (NDA) and Biologic License Applications (BLA) with oncology...

DA: 32 PA: 70 MOZ Rank: 14

Analysis of the Real-Time Oncology Review (RTOR) Pilot …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8081281/

WEBApr 28, 2021 · RTOR applications spanned a wide range of oncologic indications with the highest number for breast cancer (4), chronic lymphocytic leukemia/small lymphocytic lymphoma (4), multiple myeloma (3), and non-small cell lung cancer (3). Supplements to initial marketing applications were mainly filed to support new indications (21) with a …

DA: 41 PA: 52 MOZ Rank: 96

Real-Time Oncology Review (RTOR) - U.S. Food and Drug …
fda.gov

https://www.fda.gov/media/173641/download

WEBOffice of Communications, Division of Drug Information. Center for Drug Evaluation and Research. Food and Drug Administration. 10001 New Hampshire Ave., Hillandale Bldg., 4th Floor. Silver Spring ...

DA: 34 PA: 8 MOZ Rank: 100

Real-Time Oncology Review; Guidance for Industry; Availability
federalregister.gov

https://www.federalregister.gov/documents/2023/11/08/2023-24712/real-time-oncology-review-guidance-for-industry-availability

WEBNov 8, 2023 · SUMMARY: The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance for industry entitled “Real-Time Oncology Review (RTOR).”

DA: 28 PA: 17 MOZ Rank: 59

U.S. Food and Drug Administration: Initial Experience with the …
aacrjournals.org

https://aacrjournals.org/clincancerres/article/27/1/11/83387/U-S-Food-and-Drug-Administration-Initial

WEBJan 4, 2021 · RTOR is not designed to receive live updates of clinical trial data. This article summarizes the initial experience (February 2018 to April 2020) with the RTOR program, which was used to support drug approvals for 20 oncology applications at FDA Center for Drug Evaluation and Research (CDER).

DA: 38 PA: 38 MOZ Rank: 84

U.S. Food and Drug Administration: Initial Experience with the …
nih.gov

https://pubmed.ncbi.nlm.nih.gov/32816899/

WEBJan 1, 2021 · PMID: 32816899. DOI: 10.1158/1078-0432.CCR-20-2220. Abstract. The FDA Oncology Center of Excellence commenced the Real-Time Oncology Review (RTOR) pilot project in February 2018 to facilitate earlier submission of topline results and datasets to support an earlier start to the FDA application review.

DA: 63 PA: 100 MOZ Rank: 91

Analysis of the Real-Time Oncology Review (RTOR) Pilot Program …
nih.gov

https://pubmed.ncbi.nlm.nih.gov/33913098/

WEBApplicants must also meet certain criteria regarding the clinical trial design and development program to be eligible for RTOR. Publicly available databases (Drugs@FDA) and documents were searched for all RTOR applications, which revealed a total of 28 approved applications that participated from February 2018 to August 2020.

DA: 32 PA: 33 MOZ Rank: 38

Meeting report: Advancing accelerated regulatory review with …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9734574/

WEBDec 5, 2022 · Real-Time Oncology Review (RTOR), Project Orbis, and the Assessment Aid (AAid) are the OCE initiatives highlighted in this meeting report. RTOR, Project Orbis, and the AAid serve to further accelerate review, and in the case of Project Orbis, potentially result in streamlined reviews of applications to multiple countries.

DA: 100 PA: 43 MOZ Rank: 16

FDA’s RTOR Program Draft Guidance Insights - Clinical Leader
clinicalleader.com

https://www.clinicalleader.com/doc/fda-s-rtor-program-draft-guidance-insights-0001

WEBOct 4, 2022 · First launched in Feb. 2018 by the FDA’s Oncology Center of Excellence, the Real-Time Oncology Review (RTOR) program is intended to streamline the review process for oncology drug applications. This article summarizes the new guidance and reviews the performance of the program thus far.

DA: 96 PA: 11 MOZ Rank: 4

Alexa Rank

GLOBAL RANK

499,703

Alexa Reach

0.0002782287

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

6,303

Monthly Unique Visitors

189,083

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

40,445

Indonesia

31,634

Taiwan

10,286

United Kingdom

9,133

Brazil

8,263

Nigeria

7,223

Egypt

6,070

Hong Kong

5,729

Canada

5,729

Australia

4,992

Philippines

3,574

India

3,479

Malaysia

3,422

Spain

2,836

Germany

2,761

Mexico

2,647

France

2,496

Italy

2,307

Turkey

2,118

Iraq

1,929

Thailand

1,891

Netherlands

1,815

Israel

1,796

Cambodia

1,494

Algeria

1,153

Ireland

1,040

Romania

1,002

Jordan

927

Poland

889

Ghana

851

Argentina

813

South Africa

737

Belgium

662

Czechia

605

Ukraine

567

Japan

567

Morocco

548

South Korea

529

Lebanon

511

Saudi Arabia

492

Austria

473

Hungary

454

Sweden

435

Singapore

416

Pakistan

397

Bangladesh

378

Denmark

359

Greece

340

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Host	Type	Class	TTL	Extra
rtor.org	TXT	IN	3600	Txt: MS=ms69964544 Entries_0: MS=ms69964544
rtor.org	TXT	IN	3600	Txt: v=spf1 include:spf.protection.outlook.com -all Entries_0: v=spf1 include:spf.protection.outlook.com -all
rtor.org	MX	IN	3600	Pri: 10 Target: rtor-org.mail.protection.outlook.com
rtor.org	SOA	IN	21600	Mname: ns-cloud-c1.googledomains.com Rname: cloud-dns-hostmaster.google.com Serial: 41 Refresh: 21600 Retry: 3600 Expire: 259200 Minimum-ttl: 300
rtor.org	NS	IN	21600	Target: ns-cloud-c3.googledomains.com
rtor.org	NS	IN	21600	Target: ns-cloud-c4.googledomains.com
rtor.org	NS	IN	21600	Target: ns-cloud-c2.googledomains.com
rtor.org	NS	IN	21600	Target: ns-cloud-c1.googledomains.com
rtor.org	A	IN	120	Ip: 162.252.214.163

Hosting and Whois Zone

IP	162.252.214.163
Domain infomation	Domain Name: rtor.org Registry Domain ID: 9970df141e5f45a4a1c30e04ae9db581-LROR Registrar WHOIS Server: whois.squarespace.domains Registrar URL: https://domains.squarespace.com Updated Date: 2024-03-23T19:03:20Z Creation Date: 2011-03-23T19:03:12Z Registry Expiry Date: 2025-03-23T19:03:12Z Registrar: Squarespace Domains II LLC Registrar IANA ID: 895 Registrar Abuse Contact Email: [email protected] Registrar Abuse Contact Phone: +1.6466935324 Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: autoRenewPeriod https://icann.org/epp#autoRenewPeriod Registry Registrant ID: REDACTED FOR PRIVACY Registrant Name: REDACTED FOR PRIVACY Registrant Organization: Contact Privacy Inc. Customer 7151571251 Registrant Street: REDACTED FOR PRIVACY Registrant City: REDACTED FOR PRIVACY Registrant State/Province: ON Registrant Postal Code: REDACTED FOR PRIVACY Registrant Country: CA Registrant Phone: REDACTED FOR PRIVACY Registrant Phone Ext: REDACTED FOR PRIVACY Registrant Fax: REDACTED FOR PRIVACY Registrant Fax Ext: REDACTED FOR PRIVACY Registrant Email: Please query the RDDS service of the Registrar of Record identified in this output for information on how to contact the Registrant, Admin, or Tech contact of the queried domain name. Registry Admin ID: REDACTED FOR PRIVACY Admin Name: REDACTED FOR PRIVACY Admin Organization: REDACTED FOR PRIVACY Admin Street: REDACTED FOR PRIVACY Admin City: REDACTED FOR PRIVACY Admin State/Province: REDACTED FOR PRIVACY Admin Postal Code: REDACTED FOR PRIVACY Admin Country: REDACTED FOR PRIVACY Admin Phone: REDACTED FOR PRIVACY Admin Phone Ext: REDACTED FOR PRIVACY Admin Fax: REDACTED FOR PRIVACY Admin Fax Ext: REDACTED FOR PRIVACY Admin Email: Please query the RDDS service of the Registrar of Record identified in this output for information on how to contact the Registrant, Admin, or Tech contact of the queried domain name. Registry Tech ID: REDACTED FOR PRIVACY Tech Name: REDACTED FOR PRIVACY Tech Organization: REDACTED FOR PRIVACY Tech Street: REDACTED FOR PRIVACY Tech City: REDACTED FOR PRIVACY Tech State/Province: REDACTED FOR PRIVACY Tech Postal Code: REDACTED FOR PRIVACY Tech Country: REDACTED FOR PRIVACY Tech Phone: REDACTED FOR PRIVACY Tech Phone Ext: REDACTED FOR PRIVACY Tech Fax: REDACTED FOR PRIVACY Tech Fax Ext: REDACTED FOR PRIVACY Tech Email: Please query the RDDS service of the Registrar of Record identified in this output for information on how to contact the Registrant, Admin, or Tech contact of the queried domain name. Name Server: ns-cloud-c1.googledomains.com Name Server: ns-cloud-c2.googledomains.com Name Server: ns-cloud-c3.googledomains.com Name Server: ns-cloud-c4.googledomains.com DNSSEC: unsigned URL of the ICANN Whois Inaccuracy Complaint Form: https://www.icann.org/wicf/ >>> Last update of WHOIS database: 2024-04-18T15:01:54Z <<< For more information on Whois status codes, please visit https://icann.org/epp Terms of Use: Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Identity Digital except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy. The Registrar of Record identified in this output may have an RDDS service that can be queried for additional information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.